首页 > 最新文献

Lancet Regional Health-Americas最新文献

英文 中文
Sex differences in the association of vascular risk and APOE Genotype with cognitive decline and dementia: evidence from a U.S. longitudinal study 血管风险和APOE基因型与认知能力下降和痴呆相关的性别差异:来自美国纵向研究的证据
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-12-26 DOI: 10.1016/j.lana.2025.101346
Longjian Liu , Jintong Hou , Saishi Cui , Xiaopeng Zhao , Zuolu Liu , J. Craig Longenecker , Nathalie S. May , Jin Jun Luo , Rose Ann DiMaria-Ghalili , Howard J. Eisen

Background

Sex differences in the association between vascular factors and cognitive outcomes remain unclear. We aimed to investigate the associations of blood pressure metrics (hypertension, systolic blood pressure [SBP), pulse pressure, ankle and brachial pressures, and ankle to brachial pressure index [ABI]) with the risk of cognitive decline and dementia.

Methods

We conducted a population-based longitudinal analysis using data from the Atherosclerosis Risk in Communities (ARIC) study (begun in 1987–1989) in the United States. We analyzed a total of 12,268 participants aged 45–64 years who had validated exposure measurements, cognitive function tests (first administrated 1990–1992), and followed up for incidence of dementia through December 2019. Cognitive function was assessed using the Digit Symbol Substitution Test, the Delayed Word Recall Test, and the Word Fluency Test. Dementia cases were identified through a standardized clinical evaluation process, mostly adjudicated by expert reviewers. We performed sex-stratified analyses to examine the associations of blood pressure metrics and APOE ε4 allele with the risk of cognitive decline and dementia.

Findings

Over a median follow-up of 26.4 years, 2698 participants developed dementia. Women aged 55–64 had a significantly higher incidence of dementia than men aged 55–64 (14.8 vs. 11.8 per 1000 person-years; p < 0.0001). After adjusting for key covariates, SBP, pulse pressure, ankle and brachial pressures were significantly associated with cognitive decline in women (p < 0.05). In men, pulse pressure and ankle pressure showed a significant association. In longitudinal analyses, baseline hypertension and elevated brachial pressure were significantly associated with increased dementia risk in women, whereas in men, elevated brachial pressure and decreased ABI were significantly associated with dementia risk. Individuals with APOE ε4 allele had significantly higher risk of dementia in both sexes. A joint effect of APOE ε4 allele and elevated blood pressure metrics conferred a greater relative excess risk of dementia in women vs. men.

Interpretation

These findings highlight notable sex differences in the association between vascular factors and cognitive decline and dementia risk. Women appear more vulnerable to both genetic and vascular risk factors, emphasizing the need for sex-specific approaches in research, prevention, and intervention strategies for cognitive impairment.

Funding

NIH.
背景血管因素与认知结果之间的性别差异尚不清楚。我们的目的是研究血压指标(高血压、收缩压(SBP)、脉压、踝和肱压力以及踝肱压力指数[ABI])与认知能力下降和痴呆风险的关系。方法:我们使用美国社区动脉粥样硬化风险(ARIC)研究(始于1987-1989年)的数据进行了一项基于人群的纵向分析。我们共分析了12268名年龄在45-64岁之间的参与者,他们进行了有效的暴露测量、认知功能测试(首次进行于1990-1992年),并随访了到2019年12月的痴呆症发病率。认知功能通过数字符号替代测试、延迟单词回忆测试和单词流畅性测试进行评估。痴呆症病例是通过标准化的临床评估过程确定的,主要由专家评审人员裁定。我们进行了性别分层分析,以检验血压指标和APOE ε4等位基因与认知能力下降和痴呆风险的关系。在中位26.4年的随访中,2698名参与者患上了痴呆症。55-64岁女性的痴呆发病率明显高于55-64岁男性(14.8 vs 11.8 / 1000人年;p < 0.0001)。调整关键协变量后,收缩压、脉压、踝压和肱压与女性认知能力下降显著相关(p < 0.05)。在男性中,脉压和踝压显示出显著的相关性。在纵向分析中,基线高血压和臂压升高与女性痴呆风险增加显著相关,而在男性中,臂压升高和ABI降低与痴呆风险显著相关。携带APOE ε4等位基因的个体在两性中痴呆风险均显著增高。APOE ε4等位基因和升高的血压指标的共同作用使女性患痴呆的相对风险高于男性。这些发现强调了血管因素与认知能力下降和痴呆风险之间的显著性别差异。女性似乎更容易受到遗传和血管危险因素的影响,这强调了在认知障碍的研究、预防和干预策略中需要针对性别的方法。
{"title":"Sex differences in the association of vascular risk and APOE Genotype with cognitive decline and dementia: evidence from a U.S. longitudinal study","authors":"Longjian Liu ,&nbsp;Jintong Hou ,&nbsp;Saishi Cui ,&nbsp;Xiaopeng Zhao ,&nbsp;Zuolu Liu ,&nbsp;J. Craig Longenecker ,&nbsp;Nathalie S. May ,&nbsp;Jin Jun Luo ,&nbsp;Rose Ann DiMaria-Ghalili ,&nbsp;Howard J. Eisen","doi":"10.1016/j.lana.2025.101346","DOIUrl":"10.1016/j.lana.2025.101346","url":null,"abstract":"<div><h3>Background</h3><div>Sex differences in the association between vascular factors and cognitive outcomes remain unclear. We aimed to investigate the associations of blood pressure metrics (hypertension, systolic blood pressure [SBP), pulse pressure, ankle and brachial pressures, and ankle to brachial pressure index [ABI]) with the risk of cognitive decline and dementia.</div></div><div><h3>Methods</h3><div>We conducted a population-based longitudinal analysis using data from the Atherosclerosis Risk in Communities (ARIC) study (begun in 1987–1989) in the United States. We analyzed a total of 12,268 participants aged 45–64 years who had validated exposure measurements, cognitive function tests (first administrated 1990–1992), and followed up for incidence of dementia through December 2019. Cognitive function was assessed using the Digit Symbol Substitution Test, the Delayed Word Recall Test, and the Word Fluency Test. Dementia cases were identified through a standardized clinical evaluation process, mostly adjudicated by expert reviewers. We performed sex-stratified analyses to examine the associations of blood pressure metrics and APOE ε4 allele with the risk of cognitive decline and dementia.</div></div><div><h3>Findings</h3><div>Over a median follow-up of 26.4 years, 2698 participants developed dementia. Women aged 55–64 had a significantly higher incidence of dementia than men aged 55–64 (14.8 vs. 11.8 per 1000 person-years; p &lt; <em>0.0001</em>). After adjusting for key covariates, SBP, pulse pressure, ankle and brachial pressures were significantly associated with cognitive decline in women (p &lt; 0.05). In men, pulse pressure and ankle pressure showed a significant association. In longitudinal analyses, baseline hypertension and elevated brachial pressure were significantly associated with increased dementia risk in women, whereas in men, elevated brachial pressure and decreased ABI were significantly associated with dementia risk. Individuals with APOE ε4 allele had significantly higher risk of dementia in both sexes. A joint effect of APOE ε4 allele and elevated blood pressure metrics conferred a greater relative excess risk of dementia in women vs. men.</div></div><div><h3>Interpretation</h3><div>These findings highlight notable sex differences in the association between vascular factors and cognitive decline and dementia risk. Women appear more vulnerable to both genetic and vascular risk factors, emphasizing the need for sex-specific approaches in research, prevention, and intervention strategies for cognitive impairment.</div></div><div><h3>Funding</h3><div><span>NIH</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101346"},"PeriodicalIF":7.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145840624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From detecting abnormalities to diagnosing cancer: how can lay anal examinations be refined? 从发现异常到诊断癌症:如何改进肛门检查?
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-01-29 DOI: 10.1016/j.lana.2026.101380
Ming Wang, Yanru Cao, Qing Zhu
{"title":"From detecting abnormalities to diagnosing cancer: how can lay anal examinations be refined?","authors":"Ming Wang,&nbsp;Yanru Cao,&nbsp;Qing Zhu","doi":"10.1016/j.lana.2026.101380","DOIUrl":"10.1016/j.lana.2026.101380","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101380"},"PeriodicalIF":7.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of eggs on Maya child development and growth: the Saqmolo’ Project randomized clinical trial 鸡蛋对玛雅儿童发育和生长的影响:Saqmolo项目随机临床试验
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2025-12-20 DOI: 10.1016/j.lana.2025.101339
Gabriela Montenegro-Bethancourt , Gabriela V. Proaño , Elizabeth Yakes Jimenez , Taylor C. Wallace , Alison Steiber , Xingya Ma , Ming Ji , Peter Rohloff

Background

There is worldwide interest in determining whether frequent egg provision during complementary feeding enhances child development and growth in low-resource settings. We evaluated effects of adding one whole egg per day to local standard nutrition care on infant outcomes.

Methods

The Saqmolo’ Project individually randomized, partially blinded, comparative effectiveness clinical trial was conducted in rural Guatemala from 2021 to 2023. Maya infants aged 6–9 months were randomized to standard nutrition care alone (growth monitoring, complementary and responsive feeding education, deworming medication, multiple micronutrient powders, and referrals for medical care) versus standard care plus one whole egg per day for 6 months. Mixed linear or logistic regression models were used to estimate between-group differences in primary (global development score) and secondary (growth, anemia status, and diet quality) outcomes.

Findings

This trial included 1200 Maya infants (51.3% male). After adjustment for baseline values and participant characteristics, there was no significant between-group difference in global development score (β −0.08 points [95% CI −0.22 to 0.06]). There were also no significant between-group differences for most secondary outcomes. Intervention participants did have significantly higher odds of stunting (odds ratio [OR] 1.42 [95% CI 1.10–1.82]; p = 0.007) and of meeting minimum dietary diversity (OR 1.41 [95% CI 1.20–1.65]; p < 0.001) and minimum adequate diet (OR 1.44 [95% CI 1.26–1.64]; p < 0.001) benchmarks than standard care participants.

Interpretation

Provision of one whole egg per day in addition to standard care improved diet quality but did not benefit development, growth, or anemia status among Maya infants.

Funding

Academy of Nutrition and Dietetics Foundation via an Egg Nutrition Center investigator-initiated research grant.
在低资源环境下,确定补充喂养期间频繁提供鸡蛋是否能促进儿童发育和生长,是全世界都感兴趣的问题。我们评估了在当地标准营养护理中每天添加一个全蛋对婴儿结局的影响。方法于2021 - 2023年在危地马拉农村地区进行Saqmolo项目随机、部分盲法临床试验。6 - 9个月的玛雅婴儿被随机分配到单独的标准营养护理组(生长监测、补充和反应性喂养教育、驱虫药物、多种微量营养素粉末和转诊医疗护理组)和标准护理组,每天加一个完整的鸡蛋,持续6个月。使用混合线性或逻辑回归模型来估计主要(总体发展评分)和次要(生长、贫血状况和饮食质量)结局的组间差异。该试验包括1200名玛雅婴儿(51.3%为男性)。调整基线值和参与者特征后,总体发展评分组间无显著差异(β - 0.08分[95% CI - 0.22 - 0.06])。在大多数次要结果方面,组间也没有显著差异。与标准护理参与者相比,干预参与者发育迟缓的几率(比值比[OR] 1.42 [95% CI 1.10-1.82]; p = 0.007)、满足最低饮食多样性(比值比[OR] 1.41 [95% CI 1.20-1.65]; p < 0.001)和最低适当饮食(比值比[OR] 1.44 [95% CI 1.26-1.64]; p < 0.001)的几率明显更高。解释:除了标准护理外,每天提供一个全蛋改善了玛雅婴儿的饮食质量,但对发育、生长或贫血状况没有好处。营养与饮食学会基金会通过鸡蛋营养中心研究者发起的研究资助。
{"title":"Effect of eggs on Maya child development and growth: the Saqmolo’ Project randomized clinical trial","authors":"Gabriela Montenegro-Bethancourt ,&nbsp;Gabriela V. Proaño ,&nbsp;Elizabeth Yakes Jimenez ,&nbsp;Taylor C. Wallace ,&nbsp;Alison Steiber ,&nbsp;Xingya Ma ,&nbsp;Ming Ji ,&nbsp;Peter Rohloff","doi":"10.1016/j.lana.2025.101339","DOIUrl":"10.1016/j.lana.2025.101339","url":null,"abstract":"<div><h3>Background</h3><div>There is worldwide interest in determining whether frequent egg provision during complementary feeding enhances child development and growth in low-resource settings. We evaluated effects of adding one whole egg per day to local standard nutrition care on infant outcomes.</div></div><div><h3>Methods</h3><div>The Saqmolo’ Project individually randomized, partially blinded, comparative effectiveness clinical trial was conducted in rural Guatemala from 2021 to 2023. Maya infants aged 6–9 months were randomized to standard nutrition care alone (growth monitoring, complementary and responsive feeding education, deworming medication, multiple micronutrient powders, and referrals for medical care) versus standard care plus one whole egg per day for 6 months. Mixed linear or logistic regression models were used to estimate between-group differences in primary (global development score) and secondary (growth, anemia status, and diet quality) outcomes.</div></div><div><h3>Findings</h3><div>This trial included 1200 Maya infants (51.3% male). After adjustment for baseline values and participant characteristics, there was no significant between-group difference in global development score (β −0.08 points [95% CI −0.22 to 0.06]). There were also no significant between-group differences for most secondary outcomes. Intervention participants did have significantly higher odds of stunting (odds ratio [OR] 1.42 [95% CI 1.10–1.82]; p = 0.007) and of meeting minimum dietary diversity (OR 1.41 [95% CI 1.20–1.65]; p &lt; 0.001) and minimum adequate diet (OR 1.44 [95% CI 1.26–1.64]; p &lt; 0.001) benchmarks than standard care participants.</div></div><div><h3>Interpretation</h3><div>Provision of one whole egg per day in addition to standard care improved diet quality but did not benefit development, growth, or anemia status among Maya infants.</div></div><div><h3>Funding</h3><div><span>Academy of Nutrition and Dietetics Foundation</span> via an <span>Egg Nutrition Center investigator-initiated research</span> grant.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101339"},"PeriodicalIF":7.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis” - The Lancet Regional Health – Americas 2025; Volume 41: 100963; DOI: 10.1016/j.lana.2024.100963 《战略公共卫生干预措施对减少巴西结核病发病率的影响:贝叶斯结构时序情景分析》的更正——《柳叶刀》区域卫生——2025年美洲版;卷41:100963;DOI: 10.1016 / j.lana.2024.100963
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-01-29 DOI: 10.1016/j.lana.2026.101381
Klauss Villalva-Serra , Beatriz Barreto-Duarte , Moreno M. Rodrigues , Artur T.L. Queiroz , Leonardo Martinez , Julio Croda , Valeria C. Rolla , Afrânio L. Kritski , Marcelo Cordeiro-Santos , Timothy R. Sterling , Mariana Araújo-Pereir , Bruno B. Andrade
{"title":"Corrigendum to “Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis” - The Lancet Regional Health – Americas 2025; Volume 41: 100963; DOI: 10.1016/j.lana.2024.100963","authors":"Klauss Villalva-Serra ,&nbsp;Beatriz Barreto-Duarte ,&nbsp;Moreno M. Rodrigues ,&nbsp;Artur T.L. Queiroz ,&nbsp;Leonardo Martinez ,&nbsp;Julio Croda ,&nbsp;Valeria C. Rolla ,&nbsp;Afrânio L. Kritski ,&nbsp;Marcelo Cordeiro-Santos ,&nbsp;Timothy R. Sterling ,&nbsp;Mariana Araújo-Pereir ,&nbsp;Bruno B. Andrade","doi":"10.1016/j.lana.2026.101381","DOIUrl":"10.1016/j.lana.2026.101381","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101381"},"PeriodicalIF":7.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors’ reply to: Todd et al., prenatal and intrapartum antibiotic exposure and childhood infections: considerations and complexities 作者回复:Todd等人,产前和产时抗生素暴露与儿童感染:考虑因素和复杂性
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-01 Epub Date: 2026-01-09 DOI: 10.1016/j.lana.2025.101369
Sarah A. Coggins , Sagori Mukhopadhyay
{"title":"Authors’ reply to: Todd et al., prenatal and intrapartum antibiotic exposure and childhood infections: considerations and complexities","authors":"Sarah A. Coggins ,&nbsp;Sagori Mukhopadhyay","doi":"10.1016/j.lana.2025.101369","DOIUrl":"10.1016/j.lana.2025.101369","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101369"},"PeriodicalIF":7.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145920762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unique role of the prospective cohort incident-tumor biobank method in etiological research 前瞻性队列事件肿瘤生物库方法在病因学研究中的独特作用
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 Epub Date: 2025-11-07 DOI: 10.1016/j.lana.2025.101290
Shuji Ogino , Alpa V. Patel , Satoko Ugai , Marios Giannakis , Tomotaka Ugai
{"title":"Unique role of the prospective cohort incident-tumor biobank method in etiological research","authors":"Shuji Ogino ,&nbsp;Alpa V. Patel ,&nbsp;Satoko Ugai ,&nbsp;Marios Giannakis ,&nbsp;Tomotaka Ugai","doi":"10.1016/j.lana.2025.101290","DOIUrl":"10.1016/j.lana.2025.101290","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101290"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health and economic burden of insomnia medications among older Americans: findings from the future elderly model 美国老年人失眠药物的健康和经济负担:来自未来老年模型的发现
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 Epub Date: 2025-12-12 DOI: 10.1016/j.lana.2025.101333
Christopher N. Kaufmann , Adam P. Spira , Chien-Yu Tseng , Emerson M. Wickwire
{"title":"Health and economic burden of insomnia medications among older Americans: findings from the future elderly model","authors":"Christopher N. Kaufmann ,&nbsp;Adam P. Spira ,&nbsp;Chien-Yu Tseng ,&nbsp;Emerson M. Wickwire","doi":"10.1016/j.lana.2025.101333","DOIUrl":"10.1016/j.lana.2025.101333","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101333"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suicide-related outcomes in veterans with post-traumatic headache: a retrospective cohort study 创伤后头痛退伍军人的自杀相关结果:一项回顾性队列研究
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 Epub Date: 2025-11-13 DOI: 10.1016/j.lana.2025.101299
Sarah E. Anthony , Manali A. Phadke , Richard B. Lipton , Daniel G. Rogers , Lisa A. Brenner , John P. Ney , Hamada H. Altalib , X. Michelle Androulakis , Amy S. Grinberg , Melissa Skanderson , Hung-Mo Lin , Joel D. Scholten , Brenda T. Fenton , Elizabeth K. Seng , Jason J. Sico

Background

Post-traumatic headache (PTH) is a common sequela of traumatic brain injury (TBI). Although there is a known association between TBI and suicide risk in veterans, the association between PTH and suicide-related outcomes in veterans with TBI is relatively unknown. We aimed to evaluate the association between PTH and suicide-related outcomes in veterans compared to matched controls diagnosed with TBI but no history of headaches.

Methods

This retrospective cohort study was conducted with Veterans Health Administration and Department of Defense electronic health record data from fiscal years 2008 through 2020. Veterans with PTH were matched to a control group who had TBI and no headache disorders. Relative risk was estimated using propensity score-weighted log-binomial models that evaluated differences in suicidal ideation, suicide attempts, and suicide death.

Findings

Of the 95,224 veterans included in the total sample, 85,730 were male (90.0%) and 9,949 were female (10.0%). The average age of the sample was 45.9 years (SD = 16.6). 73,500 (77.2%) were White, Non-Hispanic, 17,256 (18.1%) were Black, Non-Hispanic, and 4,468 (4.7%) were classified as other or mixed race. Of the 47,612 veterans diagnosed with PTH, 4,618 (9.7%) reported suicidal ideation or suicide attempts compared to 3,162 (6.6%) in the control group. Veterans with PTH had increased risk of suicidal ideation (RR, 1.45; 95% CI, 1.39–1.51) and suicide attempts (RR, 1.66; 95% CI, 1.50–1.83) compared to matched controls. Using inverse probability weighting to adjust for confounding, these results remained significant. When adjusting for potential confounders, as well as prior suicidal ideation or suicide attempts, there was no significant difference in risk of suicide death in veterans with PTH (RR, 0.83; 95% CI, 0.67–1.02) compared to those with TBI without headache.

Interpretation

Veterans with PTH have an increased risk of suicidal ideation and suicide attempts compared to veterans with TBI and without headache. There was no difference in suicide mortality between the two groups. Clinicians should be aware of heightened suicide risk among veterans with PTH and be especially diligent in terms of screening for suicide risk and related medical and mental health comorbidities that contribute to increased risk.

Funding

This study was supported by the United States Department of Veterans Affairs special purpose medical service funding (SP80DPE.1-0160).
背景:创伤后头痛(PTH)是创伤性脑损伤(TBI)的常见后遗症。虽然已知创伤性脑损伤与退伍军人自杀风险之间存在关联,但PTH与创伤性脑损伤退伍军人自杀相关结果之间的关联相对未知。我们的目的是评估PTH与退伍军人自杀相关结果之间的关系,与诊断为TBI但没有头痛史的对照组相比。方法采用2008 - 2020财政年度退伍军人健康管理局和国防部电子健康记录数据进行回顾性队列研究。患有甲状旁腺激素的退伍军人与没有头痛疾病的TBI对照组相匹配。使用倾向评分加权对数二项模型估计相对风险,评估自杀意念、自杀企图和自杀死亡的差异。结果:在总样本的95224名退伍军人中,男性85730人(90.0%),女性9949人(10.0%)。样本平均年龄为45.9岁(SD = 16.6)。73,500人(77.2%)为白人,非西班牙裔,17,256人(18.1%)为黑人,非西班牙裔,4,468人(4.7%)为其他或混合种族。在47,612名被诊断患有甲状旁腺激素的退伍军人中,4,618名(9.7%)报告有自杀意念或自杀企图,而对照组为3,162名(6.6%)。与对照组相比,患有甲状旁腺激素的退伍军人有自杀意念(RR, 1.45; 95% CI, 1.39-1.51)和自杀企图(RR, 1.66; 95% CI, 1.50-1.83)的风险增加。使用逆概率加权来调整混杂因素,这些结果仍然显著。当调整潜在混杂因素,以及先前的自杀意念或自杀企图时,与没有头痛的TBI患者相比,PTH退伍军人的自杀死亡风险没有显著差异(RR, 0.83; 95% CI, 0.67-1.02)。与创伤性脑损伤和无头痛的退伍军人相比,患有甲状旁腺激素的退伍军人有更高的自杀意念和自杀企图的风险。两组之间的自杀死亡率没有差异。临床医生应该意识到患有甲状旁腺瘤的退伍军人自杀风险的增加,并在筛查自杀风险和相关的医疗和精神健康合并症方面特别勤奋,这些合并症会增加自杀风险。本研究由美国退伍军人事务部特殊目的医疗服务基金(SP80DPE.1-0160)支持。
{"title":"Suicide-related outcomes in veterans with post-traumatic headache: a retrospective cohort study","authors":"Sarah E. Anthony ,&nbsp;Manali A. Phadke ,&nbsp;Richard B. Lipton ,&nbsp;Daniel G. Rogers ,&nbsp;Lisa A. Brenner ,&nbsp;John P. Ney ,&nbsp;Hamada H. Altalib ,&nbsp;X. Michelle Androulakis ,&nbsp;Amy S. Grinberg ,&nbsp;Melissa Skanderson ,&nbsp;Hung-Mo Lin ,&nbsp;Joel D. Scholten ,&nbsp;Brenda T. Fenton ,&nbsp;Elizabeth K. Seng ,&nbsp;Jason J. Sico","doi":"10.1016/j.lana.2025.101299","DOIUrl":"10.1016/j.lana.2025.101299","url":null,"abstract":"<div><h3>Background</h3><div>Post-traumatic headache (PTH) is a common sequela of traumatic brain injury (TBI). Although there is a known association between TBI and suicide risk in veterans, the association between PTH and suicide-related outcomes in veterans with TBI is relatively unknown. We aimed to evaluate the association between PTH and suicide-related outcomes in veterans compared to matched controls diagnosed with TBI but no history of headaches.</div></div><div><h3>Methods</h3><div>This retrospective cohort study was conducted with Veterans Health Administration and Department of Defense electronic health record data from fiscal years 2008 through 2020. Veterans with PTH were matched to a control group who had TBI and no headache disorders. Relative risk was estimated using propensity score-weighted log-binomial models that evaluated differences in suicidal ideation, suicide attempts, and suicide death.</div></div><div><h3>Findings</h3><div>Of the 95,224 veterans included in the total sample, 85,730 were male (90.0%) and 9,949 were female (10.0%). The average age of the sample was 45.9 years (SD = 16.6). 73,500 (77.2%) were White, Non-Hispanic, 17,256 (18.1%) were Black, Non-Hispanic, and 4,468 (4.7%) were classified as other or mixed race. Of the 47,612 veterans diagnosed with PTH, 4,618 (9.7%) reported suicidal ideation or suicide attempts compared to 3,162 (6.6%) in the control group. Veterans with PTH had increased risk of suicidal ideation (RR, 1.45; 95% CI, 1.39–1.51) and suicide attempts (RR, 1.66; 95% CI, 1.50–1.83) compared to matched controls. Using inverse probability weighting to adjust for confounding, these results remained significant. When adjusting for potential confounders, as well as prior suicidal ideation or suicide attempts, there was no significant difference in risk of suicide death in veterans with PTH (RR, 0.83; 95% CI, 0.67–1.02) compared to those with TBI without headache.</div></div><div><h3>Interpretation</h3><div>Veterans with PTH have an increased risk of suicidal ideation and suicide attempts compared to veterans with TBI and without headache. There was no difference in suicide mortality between the two groups. Clinicians should be aware of heightened suicide risk among veterans with PTH and be especially diligent in terms of screening for suicide risk and related medical and mental health comorbidities that contribute to increased risk.</div></div><div><h3>Funding</h3><div>This study was supported by the United States <span>Department of Veterans Affairs</span> special purpose medical service funding (SP80DPE.1-0160).</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101299"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145526893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal RSV vaccination to protect infants in Brazil: a model-based cost-effectiveness analysis for incorporation into the National Immunisation Program 巴西母亲RSV疫苗接种以保护婴儿:纳入国家免疫规划的基于模型的成本效益分析
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 Epub Date: 2025-12-22 DOI: 10.1016/j.lana.2025.101356
Sophia Aguiar Monteiro Borges , Erick Ohanesian Polli , Ana Carolina Nonato , Natacha Cerchiari , Stéphane Verguet , Ana Marli Christovam Sartori , Patrícia Coelho de Soárez

Background

In Brazil, respiratory syncytial virus (RSV) is the primary cause of lower respiratory tract infections (LRTI) in children under two years of age. Maternal immunization with the bivalent RSV prefusion F protein vaccine (RSVpreF) has demonstrated high efficacy in protecting infants during their first 6 months of life against RSV-LRTI. We assessed the cost-effectiveness of implementing maternal RSV immunization in Brazil.

Methods

We utilised a decision tree model, following a birth cohort during their first year of life. The model compared two strategies: maternal vaccination and no vaccination, from both healthcare system and societal perspectives. Secondary data from Brazilian Health Information Systems, administrative databases and international literature were used. The primary outcome was the incremental cost-effectiveness ratio (ICER) expressed as incremental cost per disability-adjusted life year (DALY) averted, in 2023 USD. We applied a cost-effectiveness threshold of 8000 USD (40,000 BRL) per DALY based on Brazilian guidelines.

Findings

Introduction of RSV vaccination for pregnant women at 50% coverage would prevent around 37,000 RSV cases annually, including 9400 hospitalizations and 28,000 outpatient visits. The program would avert 80 deaths and 1660 DALYs, with an incremental cost of $49,200,000 USD from the healthcare system perspective (ICER $29,700 per DALY averted) and $48,800,000 USD from the societal perspective (ICER $29,200 per DALY averted). These ICERs exceed the acceptable cost-effectiveness Brazilian threshold. To be considered cost-effective, the vaccine dose price would need to be around $12. In sensitivity analyses, vaccine price and efficacy were the most influential parameters, as testing their uncertainty ranges resulted in the largest changes (i.e., the widest range) in the ICER. In the probabilistic sensitivity analysis, the probability that the maternal RSV immunization program is cost-effective at the Brazilian threshold of $8000 per DALY averted was 0% from the healthcare system perspective and 6% from the societal perspective.

Interpretation

Our findings indicate maternal RSV immunization could substantially reduce disease burden but would require significant price reduction to meet Brazil's cost-effectiveness threshold.

Funding

São Paulo Research Foundation (FAPESP), Pan American Health Organization (PAHO) and Brazilian National Council for Scientific and Technological Development (CNPq).
在巴西,呼吸道合胞病毒(RSV)是2岁以下儿童下呼吸道感染(LRTI)的主要原因。母亲接种二价RSV预融合F蛋白疫苗(RSVpreF)在婴儿出生后头6个月内对RSV- lrti具有很高的保护作用。我们评估了在巴西实施母亲RSV免疫接种的成本效益。方法:我们采用决策树模型,对出生队列进行第一年的随访。该模型从卫生保健系统和社会的角度比较了两种策略:母亲接种疫苗和不接种疫苗。次要数据来自巴西卫生信息系统、行政数据库和国际文献。主要结局是增量成本-效果比(ICER),以2023美元表示为每个残疾调整生命年(DALY)避免的增量成本。根据巴西的指导方针,我们采用了每个DALY 8000美元(40,000巴西雷亚尔)的成本效益阈值。研究发现,在50%覆盖率的孕妇中引入RSV疫苗接种,每年可预防约37,000例RSV病例,包括9400例住院和28,000例门诊就诊。该计划将避免80例死亡和1660例伤残调整年,从医疗保健系统角度来看,增量成本为4920万美元(每避免伤残调整年为29700美元),从社会角度来看,增量成本为4880万美元(每避免伤残调整年为29200美元)。这些ICERs超过了巴西可接受的成本效益门槛。要被认为具有成本效益,疫苗剂量的价格需要在12美元左右。在敏感性分析中,疫苗价格和效力是影响最大的参数,因为测试它们的不确定范围导致ICER的最大变化(即最宽的范围)。在概率敏感性分析中,从医疗保健系统的角度来看,母亲RSV免疫规划在巴西阈值(每个DALY避免8000美元)下具有成本效益的概率为0%,从社会角度来看为6%。我们的研究结果表明,母亲RSV免疫接种可以大大减少疾病负担,但需要大幅降低价格才能达到巴西的成本效益门槛。资助:圣保罗研究基金会(FAPESP)、泛美卫生组织(PAHO)和巴西国家科学技术发展委员会(CNPq)。
{"title":"Maternal RSV vaccination to protect infants in Brazil: a model-based cost-effectiveness analysis for incorporation into the National Immunisation Program","authors":"Sophia Aguiar Monteiro Borges ,&nbsp;Erick Ohanesian Polli ,&nbsp;Ana Carolina Nonato ,&nbsp;Natacha Cerchiari ,&nbsp;Stéphane Verguet ,&nbsp;Ana Marli Christovam Sartori ,&nbsp;Patrícia Coelho de Soárez","doi":"10.1016/j.lana.2025.101356","DOIUrl":"10.1016/j.lana.2025.101356","url":null,"abstract":"<div><h3>Background</h3><div>In Brazil, respiratory syncytial virus (RSV) is the primary cause of lower respiratory tract infections (LRTI) in children under two years of age. Maternal immunization with the bivalent RSV prefusion F protein vaccine (RSVpreF) has demonstrated high efficacy in protecting infants during their first 6 months of life against RSV-LRTI. We assessed the cost-effectiveness of implementing maternal RSV immunization in Brazil.</div></div><div><h3>Methods</h3><div>We utilised a decision tree model, following a birth cohort during their first year of life. The model compared two strategies: maternal vaccination and no vaccination, from both healthcare system and societal perspectives. Secondary data from Brazilian Health Information Systems, administrative databases and international literature were used. The primary outcome was the incremental cost-effectiveness ratio (ICER) expressed as incremental cost per disability-adjusted life year (DALY) averted, in 2023 USD. We applied a cost-effectiveness threshold of 8000 USD (40,000 BRL) per DALY based on Brazilian guidelines.</div></div><div><h3>Findings</h3><div>Introduction of RSV vaccination for pregnant women at 50% coverage would prevent around 37,000 RSV cases annually, including 9400 hospitalizations and 28,000 outpatient visits. The program would avert 80 deaths and 1660 DALYs, with an incremental cost of $49,200,000 USD from the healthcare system perspective (ICER $29,700 per DALY averted) and $48,800,000 USD from the societal perspective (ICER $29,200 per DALY averted). These ICERs exceed the acceptable cost-effectiveness Brazilian threshold. To be considered cost-effective, the vaccine dose price would need to be around $12. In sensitivity analyses, vaccine price and efficacy were the most influential parameters, as testing their uncertainty ranges resulted in the largest changes (i.e., the widest range) in the ICER. In the probabilistic sensitivity analysis, the probability that the maternal RSV immunization program is cost-effective at the Brazilian threshold of $8000 per DALY averted was 0% from the healthcare system perspective and 6% from the societal perspective.</div></div><div><h3>Interpretation</h3><div>Our findings indicate maternal RSV immunization could substantially reduce disease burden but would require significant price reduction to meet Brazil's cost-effectiveness threshold.</div></div><div><h3>Funding</h3><div><span>São Paulo Research Foundation</span> (FAPESP), <span>Pan American Health Organization</span> (PAHO) and <span>Brazilian National Council for Scientific and Technological Development</span> (CNPq).</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101356"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 vaccine trust and uptake: the role of media, interpersonal and institutional trust in a large population-based survey COVID-19疫苗信任和吸收:媒体、人际和机构信任在大型人群调查中的作用
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 Epub Date: 2025-12-08 DOI: 10.1016/j.lana.2025.101324
Lara E. Coelho , Guilherme T. Goedert , Juliano Genari , Paula M. Luz , Luiz Max Carvalho , Cleber V.B.D. Santos , Daniel Csillag , Tulio Konečný , Lucia Campos Pellanda , Claudio J. Struchiner , Mariângela Freitas da Silveira , Pedro C. Hallal

Background

Vaccine uptake is critical to controlling COVID-19 and other infectious diseases, and trust in vaccines is a key determinant of vaccine coverage. This study aims to examine how individual characteristics and primary information sources during the pandemic influenced COVID-19 vaccine trust and uptake.

Methods

We performed a secondary analysis of the EPICOVID 2.0 survey, a Brazilian nationwide study (March–April 2024) that used multistage probabilistic sampling. Participants aged 18 or older from the EPICOVID 2.0 study were included in the analyses. Machine learning algorithms were employed to predict COVID-19 vaccine trust and uptake, measuring the influence of each covariate on the predicted probabilities.

Findings

Among 29,281 participants (63.9% women; median age 51 years), 60% reported trusting the COVID-19 vaccine and 72% had received ≥3 doses. Uptake strongly correlated with trust: 67% of unvaccinated or unsure participants distrusted the vaccine, while trust increased with the number of doses—62.6% (3 doses), 73.8% (4 doses), and 89.8% (≥5 doses). Gen Z adults (18–30 years) were less likely to trust the vaccine (negative influence of −0.07). Positive predictors of trust included higher education and trust in television or nurses as information sources (positive influences of 0.05, 0.09 and 0.07, respectively).

Interpretation

Trust and uptake of the COVID-19 vaccine were moderate, 60% and 72%, respectively. Gen Z adults reported greater distrust and lower uptake, while higher education was associated with increased trust. These findings highlight the need for tailored communication and health literacy interventions to improve vaccine uptake.

Funding

Brazilian Ministry of Health.
疫苗摄取对于控制COVID-19和其他传染病至关重要,对疫苗的信任是疫苗覆盖率的关键决定因素。本研究旨在研究大流行期间的个体特征和主要信息来源如何影响COVID-19疫苗的信任和吸收。方法:我们对EPICOVID 2.0调查进行了二次分析,这是一项巴西全国性研究(2024年3月至4月),采用了多阶段概率抽样。来自EPICOVID 2.0研究的18岁及以上的参与者被纳入分析。采用机器学习算法预测COVID-19疫苗的信任和摄取,测量每个协变量对预测概率的影响。在29,281名参与者中(63.9%为女性,中位年龄为51岁),60%的人报告相信COVID-19疫苗,72%的人接种了≥3剂疫苗。摄取与信任密切相关:67%未接种疫苗或不确定的参与者不信任疫苗,而信任随着剂量的增加而增加- 62.6%(3剂),73.8%(4剂)和89.8%(≥5剂)。Z世代成年人(18-30岁)不太可能相信疫苗(负影响为- 0.07)。信任的正向预测因子包括高等教育、对电视或护士作为信息来源的信任(正向影响分别为0.05、0.09和0.07)。对COVID-19疫苗的信任度和吸收率分别为中等、60%和72%。Z世代的成年人表现出更大的不信任和更低的接受度,而受过高等教育的人则表现出更高的信任。这些发现突出表明,需要有针对性的沟通和卫生素养干预措施,以提高疫苗的吸收率。巴西卫生部资助。
{"title":"COVID-19 vaccine trust and uptake: the role of media, interpersonal and institutional trust in a large population-based survey","authors":"Lara E. Coelho ,&nbsp;Guilherme T. Goedert ,&nbsp;Juliano Genari ,&nbsp;Paula M. Luz ,&nbsp;Luiz Max Carvalho ,&nbsp;Cleber V.B.D. Santos ,&nbsp;Daniel Csillag ,&nbsp;Tulio Konečný ,&nbsp;Lucia Campos Pellanda ,&nbsp;Claudio J. Struchiner ,&nbsp;Mariângela Freitas da Silveira ,&nbsp;Pedro C. Hallal","doi":"10.1016/j.lana.2025.101324","DOIUrl":"10.1016/j.lana.2025.101324","url":null,"abstract":"<div><h3>Background</h3><div>Vaccine uptake is critical to controlling COVID-19 and other infectious diseases, and trust in vaccines is a key determinant of vaccine coverage. This study aims to examine how individual characteristics and primary information sources during the pandemic influenced COVID-19 vaccine trust and uptake.</div></div><div><h3>Methods</h3><div>We performed a secondary analysis of the EPICOVID 2.0 survey, a Brazilian nationwide study (March–April 2024) that used multistage probabilistic sampling. Participants aged 18 or older from the EPICOVID 2.0 study were included in the analyses. Machine learning algorithms were employed to predict COVID-19 vaccine trust and uptake, measuring the influence of each covariate on the predicted probabilities.</div></div><div><h3>Findings</h3><div>Among 29,281 participants (63.9% women; median age 51 years), 60% reported trusting the COVID-19 vaccine and 72% had received ≥3 doses. Uptake strongly correlated with trust: 67% of unvaccinated or unsure participants distrusted the vaccine, while trust increased with the number of doses—62.6% (3 doses), 73.8% (4 doses), and 89.8% (≥5 doses). Gen Z adults (18–30 years) were less likely to trust the vaccine (negative influence of −0.07). Positive predictors of trust included higher education and trust in television or nurses as information sources (positive influences of 0.05, 0.09 and 0.07, respectively).</div></div><div><h3>Interpretation</h3><div>Trust and uptake of the COVID-19 vaccine were moderate, 60% and 72%, respectively. Gen Z adults reported greater distrust and lower uptake, while higher education was associated with increased trust. These findings highlight the need for tailored communication and health literacy interventions to improve vaccine uptake.</div></div><div><h3>Funding</h3><div><span>Brazilian Ministry of Health</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101324"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Regional Health-Americas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1